Retrospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Jul 19, 2023; 13(7): 453-460
Published online Jul 19, 2023. doi: 10.5498/wjp.v13.i7.453
Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
Jin-Ling Liu, Zhi-Mei Tan, Shu-Jie Jiao
Jin-Ling Liu, Shu-Jie Jiao, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
Zhi-Mei Tan, Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
Author contributions: Liu JL and Jiao SJ contributed to the study conception and design, drafting the manuscript, and data analysis and interpretation; Liu JL and Tan ZM contributed to the study conception and critical revision of the article for important intellectual content; Liu JL contributed to the study conception and design and critical revision of the article for important intellectual content.
Institutional review board statement: This study was approved by the Institutional Review Board of the First Affiliated Hospital of Zhengzhou University.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors declare having no conflicts of interest.
Data sharing statement: The data for this study can be obtained from the corresponding author upon request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shu-Jie Jiao, PhD, Doctor, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou 450000, Henan Province, China. jsj331253@126.com
Received: May 4, 2023
Peer-review started: May 4, 2023
First decision: May 15, 2023
Revised: May 31, 2023
Accepted: June 21, 2023
Article in press: June 21, 2023
Published online: July 19, 2023
Processing time: 75 Days and 4.6 Hours
Core Tip

Core Tip: Patients with treatment-refractory schizophrenia always have an unsatisfactory treatment response and prognosis despite antipsychotic therapy, which poses significant challenges to clinical management. Therefore, it is necessary to continuously explore and validate effective treatments for treatment-refractory schizophrenia.